Introduction
Nitric oxide (NO) is a key messenger involved in a wide range of biochemical processes [1] . Its role is crucial for a number of physiological functions and many pathologies can be related to its inadequate release or overproduction [2] [3] . NO is produced from the oxidation of L-arginine to citrulline [4] . The family of enzymes that catalyze this process is called Nitric Oxide Synthase (NOS) [5] and three different isoforms exist [6] . Two are constitutive forms, eNOS (e for endothelial, also known as NOS III) involved in the regulation of smooth muscle relaxation, blood pressure and inhibition of platelet aggregation [7] ; and nNOS (n for neuronal, also known as NOS I), related to neurotransmission and long-term potentiation [8] . The other isoform iNOS (i for induced, also known as NOS II) is involved in regulation of the immune system and inflammatory responses [9] . These three isoforms have unique roles in separate tissues thus making selective inhibition of either form a suitable strategy for the treatment of specific pathologies. Substantial drug development has been carried out to achieve specific inhibition of the nNOS form as a way to treat strokes and of iNOS for the treatment of septic shock and arthritis. The eNOS form, because of its important role in blood flow regulation, is seldom a clinical therapeutic target. This research has led to the discovery of a number of iNOS and to several nNOS selective inhibitors [1] .
However, there is a continuing need for new potent and selective inhibitors of either form of the enzyme as diverse pathologies are found to be linked to these enzymes. Recent work in our laboratories has shown that iNOS inhibitors, such as aminoguanidine (KI = 830 μM), attenuate inflammation in the rat lung induced by the toxic vesicant, nitrogen mustard [10] . In fact, aminoguanidine abrogated nitrogen mustard-induced injury and oxidative stress and inflammation at 1d and 3d post exposure [11] .
This finding prompted us to synthesize nitro-guanidine derivatives that displayed increased activity towards iNOS, and indeed two compounds were identified (e.g., compounds 12 and 4). Unexpectedly, most of the other compounds in this library were better nNOS and/or eNOS inhibitors. Although these latter candidates may not be selective for iNOS, they may still suppress the toxicity mediated by iNOS. Moreover, the fact that we have been able to identify nitro-guanidines which are selective for nNOS or eNOS suggests that these may be useful for pathological conditions where suppressing these isoforms of NOS may be beneficial. Other workers are pursuing selective nNOS inhibitors for therapeutic intervention in neuromuscular disorders [12] and neurodegenerative pathologies such as Alzheimer's and Parkinson's disease [13] [14] . A number of those known inhibitors are analogs of the substrate L-arginine and include, in particular, N-nitro-arginine [15] [16] . Some of them achieved not only good activity but also demonstrated excellent iNOS selectivity. Our work focused on the preparation of non-amino-acid guanidine-based analogs of N ω -nitro-arginine which has been reported to have about a 250-fold selectivity for nNOS versus iNOS [14] .
Discussion and Results

Chemistry
All the compounds prepared were synthesized through a pathway adapted from a process originally developed for the preparation of nitro-guanidines as potential fertilizers [17] - [19] . In such an approach, a commercially available reactive nitroso compound (1-methyl-3-nitro-1-nitrosoguanidine) was used to prepare the target products, as solids, in a convenient one step reaction (Scheme 1). In general, the yields ranged from 33% to 95% and for most compounds were usually greater than 60%. The details of the compounds synthesized are presented in Table 1 . When the purity of the crude compounds did not prove satisfactory, as assessed by 1 H NMR, they were easily crystallized from a number of solvents such as methanol or methanol/chloroform. Low yields (<20%) were obtained when the reacting amines were poor nucleophiles [15] [16] but the compounds could nonetheless be isolated in sufficient amounts to be tested in the NOS assays even in those cases. The purity of all those compounds was assessed by conventional analytical methods to be greater than 98%.
Biology
Once isolated and characterized, all the compounds were submitted to NOS screening for which the isolated isoforms of the enzyme were used (iNOS, nNOS and eNOS). The data obtained is summarized in -substituted guanidines. several of the NOS isoforms. In particular 1-nitro-3-(pyridin-3-yl) guanidine (15) proved active against both eNOS (0.3 μM) and nNOS (0.5 μM). As far as selectivity is concerned, we were able to identify a number of compounds displaying nNOS selectivity. One such compound, 1-((5-methylthiophen-2-yl)methyl)-3-nitroguanidine (28), although of marginal potency, nevertheless showed selectivity toward nNOS (eNOS/nNOS = 35). It is to be noted that the same compound also demonstrated nNOS over iNOS selectivity (iNOS/nNOS = 30). To a smaller extent, compounds 9 and 10 also showed nNOS selectivity with eNOS to nNOS ratios of 15 and 13 respectively. Although it was not the primary focus of this study, we also herein report some impressive nNOS over iNOS selectivity with compounds 2, 13 and 15 displaying iNOS to nNOS ratio of 62, 50 and 100 respectively. Compound 4, which had the lowest across-the-board inhibition IC 50 's for all three NOS isoforms (see Table 2 ), was tested topically for inflammation suppression in a standard mustard-induced inflamed mouse ear vesicant model [20] . In this assay 4 showed 41% suppression of inflammation compared to classic anti-inflammatory standards such as S-naproxen (11%), diclofenac (17%), indomethacin (46%), menthol (53%), or farnesol (64%) [21] . These simple guanidine mimics of the natural substrate of the enzyme, L-arginine, demonstrate that the amino acid portion of that substrate is not required to achieve activity and even selectivity toward the nNOS isoform. Guanidines can be considered a potential platform from which a more in depth SAR could be built and one that could yield even better inhibitors. 
Conclusion
We have prepared a series of N ω -nitro-N ω' -substituted guanidines in a convenient one step reaction. Evaluation of their inhibitory activity against the isoforms of NOS led to the identification of a number of hits with micromolar and one (15) with sub-micromolar potency. Among those hits, several also demonstrated selectivity toward nNOS (9, 10, 28 nNOS over eNOS selectivity and 2, 13, 15 and 28 for nNOS over iNOS selectivity). The most promising compound of this family (15) could be considered a lead candidate for further development of potent nNOS inhibitors in the class. As potential iNOS inhibitors for use in our mustard-induced lung damage model, 4, 5, 9, 12, and 15 were substantially more potent than aminoguanidine with 12 having the best margin of safety for minimal cross reactivity with nNOS and eNOS. When comparing the activities of the pyridine-containing compounds in this set, i.e., 15, 16, 17, and 18 , it is compound, 15 for which external hydrogen-bonding (both H-donor and H-acceptor) is the most probable, which has the greatest inhibition of all three isoforms. Recent crystal structure studies have claimed that precisely such external hydrogen bonding by twisted 2-aminopyridines makes these molecules important pharmacophores in inhibition of nNOS and eNOS [22] .
Experimental Section
Chemistry
1 H NMR spectra were recorded at 360 MHz and 500 MHz on a Bruker AMX-360 and DRX-500 spectrometer respectively. Chemical shifts were measured relative to CDCl 3 (δ = 7.24), CD 3 OD (δ = 3.33) or acetone-d6 (δ = 2.04) for 1 H and expressed indirectly in relation to TMS. The following abbreviations are used to describe the signal multiplicity: s (singulet), d (doublet), t (triplet), q (quadruplet) and m (multiplet). Chemical shifts are expressed in ppm and listed as follow: shift in ppm (multiplicity, coupling constant, and attribution). IR Spectra were recorded on a Mattson Polaris FT-IR spectrophotometer as NaCl discs for the crystalline samples. Thin-layer chromatography (TLC) were performed with plates (0.25 mm) pre-coated with fluorescent silica gel. Reaction components were then visualized under UV light and/or with iodine and/or with a saturated solution of KMnO 4 in aqueous NaOH (1N). Silica gel (230 -400 mesh) was used for flash chromatography separations. Uncorrected melting points (mp) were determined with a Thomas Hoover capillary melting point apparatus. Combustion analyses were provided by Intertek, Whitehouse, NJ.
1-ethyl-3-nitroguanidine (1): Ethylamine (0.235 mL, 3.60 mmol) was added dropwise, at 10˚C, to a suspension of 1-methyl-3-nitro-1-nitrosoguanidine (529 mg, 3.60 mmol) in a mixture of ethanol and water (50/50, v/v, 8 mL). After 24 h at room temperature, the reaction mixture was quenched by addition of 10 mL of NaOH (1N) and 10 mL of saturated aqueous sodium chloride. This phase was extracted 5 times with chloroform and after the usual work-up the evaporation of the organic layer afforded (209 mg, 44%) of 1 as a white solid, mp = 149˚C -150˚C. 1-nitro-3-(2,2,3,3,3-pentafluoropropyl)guanidine (5): 2,2,3,3,3-pentafluoropropylamine (0.37 mL, 3.48 mmol) was added dropwise to a suspension of 1-methyl-3-nitro-1-nitrosoguanidine (469 mg, 3.17 mmol) in a mixture of ethanol and water (50/50, v/v, 14 mL). The yellow 1-methyl-3-nitro-1-nitrosoguanidine went rapidly in solution and overtime a white precipitate formed, the remaining solution being colorless. After 20 h, the solid was collected by suction filtration, washed with cold water and dried in vacuo with the assistance of P 2 O 5 affording (688 mg, 91%) of 5 as a white solid. mp = 158.5˚C -159˚C. IR (KBr): 1534, 1651, 3307, 3426. 1-nitro-3-((tetrahydrothiophen-2-yl)methyl)guanidine(26):
The title compound was prepared according to the above procedure (compound 5) using tetrahydrofurfurylamine (0.36 mL, 3.49 mmol), 1-methyl-3-nitro-1-nitrosoguanidine (510 mg, 3.47 mmol) in a mixture of ethanol and water (50/50, v/v, 9 mL) affording (527 mg, 79%) of 26 as a white solid. mp = 84˚C -85˚C. IR (KBr): 1603, 1645, 3123, 3177, 3245, 3399. 
